The story of Viagra, and its developer copyright, presents a challenging case study for investors. Initially a blockbuster drug, generating billions in income, its intellectual property lapse created a deluge https://cruxbookmarks.com/story21483633/sildenafil-and-pharma-a-uncertain-opportunity